1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with 1-palmitoyl-lysophosphatidic acid in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (1-palmitoyl-lysophosphatidic acid) | Trials (1-palmitoyl-lysophosphatidic acid) | Recent Studies (post-2010) (1-palmitoyl-lysophosphatidic acid) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 13 | 0 | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hallam, TJ; Scrutton, MC; Wallis, RB | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 1-palmitoyl-lysophosphatidic acid
| Article | Year |
|---|---|
The role of 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (AcGEPC) and palmitoyl-lysophosphatidate in the responses of human blood platelets to collagen and thrombin.
Topics: Adenosine Triphosphate; Blood Platelets; Collagen; Dose-Response Relationship, Drug; Humans; Lysophospholipids; Phosphatidic Acids; Platelet Activating Factor; Platelet Aggregation; Thrombin | 1983 |